E6 and E7 interactions with microRNA. Oral Oncol 2014;50:e46-e47.
Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma. Hum Mol Genet 2009;18:4818-4829.
Oral potentially malignant disorders: precising the definition. Oral Oncol 2012;48:759-760.
The role of microRNAs in breast cancer stem cells. Int J Mol Sci 2013;14:14712-14723.
The functions of microRNAs and long non-coding RNAs in embryonic and induced pluripotent stem cells. Genomics Proteomics Bioinformatics 2013;11:275-283.
Friend or foe: the role of microRNA in chemotherapy resistance. Acta Pharmacologica Sinica 2013;34:870-879.
Role of microRNA-138 as a potential tumor suppressor in head and neck squamous cell carcinoma. Int Rev Cell Mol Biol 2013;303:357-385.
Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer. Br J Cancer 2012;107;700-706.
Progress risk assessment of oral premalignant lesions with saliva miRNA analysis. BMC Cancer 2013;13:129-137.
A new classification for potentially malignant disorders of the oral cavity. Oral Oncol 2011;47:920-921.
Better grade of tumor differentiation of oral squamous cell carcinoma arising in background of oral submucous fibrosis. Med Hypotheses 2013;81:540-543.